Literature DB >> 4270227

[Cellkinetic studies on Ehrlich-ascites tumor by treatment with vincristine].

R Hartenstein, H Ehrhart, K Hoffmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4270227

Source DB:  PubMed          Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol        ISSN: 0084-5353


× No keyword cloud information.
  9 in total

Review 1.  [DISORDERS IN THE COURSE OF MITOSIS. III. ON THE EFFECT OF VINCALEUKOBLASTINE ON NORMAL AND MALIGNANT CELLS IN VITRO].

Authors:  W SIEBS
Journal:  Z Zellforsch Mikrosk Anat       Date:  1963-11-05

2.  On the permeability to lissamine green and other dyes in the course of cell injury and cell death.

Authors:  B HOLMBERG
Journal:  Exp Cell Res       Date:  1961-01       Impact factor: 3.905

3.  The effect of vincaleukoblastine on dividing cells in vivo.

Authors:  J H CUTTS
Journal:  Cancer Res       Date:  1961-02       Impact factor: 12.701

4.  The action of the vincaleukolastine on mitosis in vitro.

Authors:  C G PALMER; D LIVENGOOD; A K WARREN; P J SIMPSON; I S JOHNSON
Journal:  Exp Cell Res       Date:  1960-06       Impact factor: 3.905

5.  [Impulse fluorometry of single cells in suspension].

Authors:  W Dittrich; W Göhde
Journal:  Z Naturforsch B       Date:  1969-03       Impact factor: 1.047

6.  [Sites of action of Vinca-alcaloids in protein and nucleic acid metabolism of leukemic lymphocytes in vitro. 2].

Authors:  P Warnecke; S Seeber
Journal:  Z Krebsforsch       Date:  1969-09-25

7.  [In vivo and in vitro studies on cell kinetics and synchronisation of human tumour cells: their significance in cytostatic tumour treatment].

Authors:  H O Klein; K J Lennartz; R Gross; M Eder; R Fischer
Journal:  Dtsch Med Wochenschr       Date:  1972-09-01       Impact factor: 0.628

8.  The effects of two alkaloids derived from Vinca rosea on the malignant cells of Hodgkin's disease, lymphosarcoma and acute leukemia in vivo.

Authors:  A M Marmont; E E Damasio
Journal:  Blood       Date:  1967-01       Impact factor: 22.113

9.  [Synchronization of Ehrlich ascites tumor cells and its importance in the use of an alkylating cytostatic agent].

Authors:  H O Klein; K J Lennartz; W Habicht; M Eder; R Gross
Journal:  Klin Wochenschr       Date:  1970-08-15
  9 in total
  8 in total

1.  [Experiments and theoretical cell kinetic calculations on the problem of in vivo synchronization with vincristine in L 1210 ascites tumor cells and crypt cells of the mouse (author's transl)].

Authors:  W Jellinghaus; R Maidhof; B Schultze; W Maurer
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1975-10-27

2.  [Cell cycle and carcinochemotherapy: reality or hope? (author's transl)].

Authors:  H Ehrhart
Journal:  Langenbecks Arch Chir       Date:  1975-11

3.  [A source of failure in synchronization experiments using malignant tumours in vivo (author's transl)].

Authors:  C Granzow; V Granzow
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1974-03-14

4.  Studies on the so-called "synchronization therapy" of tumors with vincristine.

Authors:  B Schultze; W Jellinghaus; U Basler; J Dettmer; W Maurer
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

5.  Treatment of artificially-induced pulmonary metastases with fractionated doses of vincristine and/or radiation therapy.

Authors:  D J Grdina; R A White
Journal:  Clin Exp Metastasis       Date:  1983 Jan-Mar       Impact factor: 5.150

6.  [Partial synchronization of tumor cells in vivo with hydroxyurea (author's transl)].

Authors:  R Hartenstein; K Pfundmair; K Possinger
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977

7.  [Effect of trenimon on single phases of the cell cycle of Yoshida ascites tumor cells (author's transl)].

Authors:  E Liss; R Averdunk; T Jungwirth; G Palme
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-08-30

8.  Cytotoxic effects of vincristine on tumour subpopulations separated from pulmonary nodules.

Authors:  D J Grdina; R A White; J J Stragand
Journal:  Br J Cancer       Date:  1983-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.